Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Net Income (2016 - 2025)

Historic Net Income for Outlook Therapeutics (OTLK) over the last 7 years, with Q4 2025 value amounting to -$13.5 million.

  • Outlook Therapeutics' Net Income changed N/A to -$13.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$93.3 million, marking a year-over-year decrease of 43316.81%. This contributed to the annual value of -$62.4 million for FY2025, which is 1717.18% up from last year.
  • Per Outlook Therapeutics' latest filing, its Net Income stood at -$13.5 million for Q4 2025.
  • Outlook Therapeutics' 5-year Net Income high stood at -$13.3 million for Q3 2025, and its period low was -$46.4 million during Q1 2025.